Related Experiment Video
Updated: May 17, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Hypertension Exacerbates Endothelial Dysfunction in Patients With Atrial Fibrillation
Samuel Thomas1, Fiona L Wilkinson1, Amy R Bland2
1Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.
None:
Atrial fibrillation (AF) and hypertension (HT) often coincide and both are independently associated with endothelial dysfunction. We tested the hypothesis that brachial artery flow-mediated dilation (FMD), an indicator of endothelial health, will be poorer in AF patients with HT (AF + HT) than AF without concurrent HT. In a cross-sectional design study, AF (n = 29; mean 70 years; 9 females) and AF + HT (n = 33; 68 years (p = 0.302); 14 females) patients underwent Duplex-Doppler ultrasound imaging of brachial artery diameter and flow velocity during baseline (2 min), distal tourniquet cuff inflation (5 min), and following cuff deflation (3 min). The peak increase in artery diameter following cuff deflation was taken as FMD and analyzed as absolute, percentage change, FMD and shear-rate area-under-the-curve (SRAUC; FMD-to-SRAUC) ratio, and using SRAUC as a covariate (FMDSRAUC). Body mass index (BMI) was used as an additional covariate for between-group comparisons of vascular data. Mean arterial pressure was higher in the AF + HT versus the AF group (median [interquartile range] 93 [85-99] vs. 84 [80-90] mm Hg, respectively; p < 0.05). Baseline brachial artery diameters were similar (p > 0.05). FMD was lower in AF + HT than AF patients (3.36 [1.69-5.21] vs. 4.98 [2.96-7.11] %, respectively; p < 0.05). Similar group differences were observed in absolute FMD, FMD-to-SRAUC ratio and FMDSRAUC (p < 0.05). AF patients with concurrent HT exhibit poorer endothelium-dependent vasodilation compared to AF patients, indicating that the presence of comorbid HT exacerbates endothelial dysfunction in AF patients.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Diuretics
Pathophysiology of Heart Failure
Antihypertensive Drugs: Angiotensin II Receptor Blockers

